285 related articles for article (PubMed ID: 7716888)
1. [Subcutaneous chamber systems (ports) for long-term care in cancer patients].
Hájek R; Sevcík P; Ondrásek J; Mayer J; Vásová I; Král Z; Tomíska M; Krahulcová E; Penka M; Kubesová H
Vnitr Lek; 1995 Jan; 41(1):21-7. PubMed ID: 7716888
[TBL] [Abstract][Full Text] [Related]
2. Radiologic placement of a low profile implantable venous access port in a pediatric population.
Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
[TBL] [Abstract][Full Text] [Related]
3. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
[TBL] [Abstract][Full Text] [Related]
4. Prolonged venous access in cancer patients.
Guenier C; Ferreira J; Pector JC
Eur J Surg Oncol; 1989 Dec; 15(6):553-5. PubMed ID: 2599125
[TBL] [Abstract][Full Text] [Related]
5. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.
Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF
Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.
Schwarz RE; Groeger JS; Coit DG
Cancer; 1997 Apr; 79(8):1635-40. PubMed ID: 9118051
[TBL] [Abstract][Full Text] [Related]
7. Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients.
Lorch H; Zwaan M; Kagel C; Weiss HD
Cardiovasc Intervent Radiol; 2001; 24(3):180-4. PubMed ID: 11443406
[TBL] [Abstract][Full Text] [Related]
8. [Application of long term subcutaneously implanted access into the central veins system of "PORT" type in the Clinic of Pediatry, Pediatric Hematology and Oncology in Zabrze--15 year own observations].
Bucki B; Tomaszewska R; Bubała H; Sońta-Jakimczyk D; Karpe J; Stoksik P
Wiad Lek; 2009; 62(2):93-8. PubMed ID: 20141056
[TBL] [Abstract][Full Text] [Related]
9. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
Koonings PP; Given FT
J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
[TBL] [Abstract][Full Text] [Related]
10. [Implantable catheter systems. Experiences with 1000 patients with central venous ports].
Kock HJ; Krause U; Pietsch M; Rasfeld S; Walz MK
Dtsch Med Wochenschr; 1996 Jan; 121(3):47-51. PubMed ID: 8565809
[TBL] [Abstract][Full Text] [Related]
11. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
[TBL] [Abstract][Full Text] [Related]
12. [Long-term central venous access in oncology. Review of a caseload of 750 cases].
Bertoglio S; Meszsaros P; Disomma C; Moresco L; Cafiero F; Gipponi M; Percivale P
Minerva Chir; 1996 Jun; 51(6):427-31. PubMed ID: 8992390
[TBL] [Abstract][Full Text] [Related]
13. [Totally implantable venous access systems. Analysis of complications].
D'Angelo F; Ramacciato G; Caramitti A; Aurello P; Lauro S; Bordin F; Della Casa U
Minerva Chir; 1997; 52(7-8):937-42. PubMed ID: 9411296
[TBL] [Abstract][Full Text] [Related]
14. [Implantable devices for central venous access in cancer patients. Our experience in 217 cases].
Torramadé J; Hernández JL; Cienfuegos JA; Albiach M; Pardo F; Benito C; González J; Voltas J
Med Clin (Barc); 1992 May; 98(19):731-3. PubMed ID: 1608278
[TBL] [Abstract][Full Text] [Related]
15. Complications associated with an implantable vascular access device.
Dillon PA; Foglia RP
J Pediatr Surg; 2006 Sep; 41(9):1582-7. PubMed ID: 16952595
[TBL] [Abstract][Full Text] [Related]
16. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.
Adler A; Yaniv I; Steinberg R; Solter E; Samra Z; Stein J; Levy I
J Hosp Infect; 2006 Mar; 62(3):358-65. PubMed ID: 16377030
[TBL] [Abstract][Full Text] [Related]
17. Totally implantable central venous access devices in pediatric oncology--our experience in 46 patients.
De Backer A; Vanhulle A; Otten J; Deconinck P
Eur J Pediatr Surg; 1993 Apr; 3(2):101-6. PubMed ID: 8323914
[TBL] [Abstract][Full Text] [Related]
18. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
Quarello F; Forneris G; Borca M; Pozzato M
J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
[TBL] [Abstract][Full Text] [Related]
19. [Percutaneous implant of Hickman catheters and reservoirs. Long-term experience].
Carreira Villamor JM; Reyes Pérez R; Pulido-Duque JM; Gorriz Gómez E; Pardo MD; Argiles Vives JM; Eyheremendy EP; Maynar Moliner M
Rev Clin Esp; 1997 Nov; 197(11):740-4. PubMed ID: 9547192
[TBL] [Abstract][Full Text] [Related]
20. Experience with the intravenous totally implanted port in patients with gynecologic malignancies.
Nelson BE; Mayer AR; Tseng PC; Schwartz PE
Gynecol Oncol; 1994 Apr; 53(1):98-102. PubMed ID: 8175028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
